is the multinational corporation servicing in health sector, mainly specialized in research, development, innovation, manufacture, and distribution of molecular & quantum biological products for human health, providing Medical Services on medicines, medical devices, in-vitro medical devices, supplements and cosmetics, standardized by regulations and standards of European Commission, with the aim of bringing the best experience to Clients and Patients on using medical products and services of Brilitas, and for the positive contribution of sustainable development of human health.
Brilitas is registered with the following Europe Commission agencies:
EUROPEAN MEDICINES AGENCY (EMA)
EUROPEAN DATABASE ON MEDICAL DEVICES (EUDAMED) No. EE-AR-000032004
By approvals from European Commission and its agencies, Brilitas becomes the full licensed corporation to be granted comprehensive rights of research, pre-clinical & clinical evaluation, registration, import & export, administration, storage, distribution and tendering in medicines, medical devices, in-vitro diagnostic medical devices, supplements and cosmetics, to offer Agencies, Partners and Clients of Brilitas a wide entrance to European Union and international market where Brilitas has its commercial presence and System of Agency & Partner Networks.